Skip to content

The study of CHEWING ability in patients with LIFEstyle disease

The study of CHEWING ability in patients with LIFEstyle disease - CHEWING-LIFE Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037849
Enrollment
1000
Registered
2019-09-30
Start date
2019-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lifestyle disease

Interventions

None listed

Sponsors

Osaka University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria are included in this study. 1) Outpatients with lifestyle diseases (at least one of diabetes mellitus, dyslipidemia, hypertension, and hyperuricemia) in Shiraiwa Medical Clinic 2) male and female who are aged of 20 years or older when giving their consent 3) patients who provide written consent form to participate in this study after full explanation of the study

Exclusion criteria

Exclusion criteria: Patients who fall into any of the following criteria are excluded from participating in the study. 1) patients who need legal representatives 2) patients who are considered inappropriate to participate in this study by physicians

Design outcomes

Primary

MeasureTime frame
Prevalence of impaired masticatory performance in patients with lifestyle diseases evaluated by Gluco Sensor GS-II

Secondary

MeasureTime frame
1. Distribution of masticatory performance in patients with lifestyle diseases evaluated by Gluco Sensor GS-II 2. Distribution of masticatory performance in patients with lifestyle diseases evaluated by colour-changeable chewing gum 3. Prevalence and distribution of oral dryness in patients with lifestyle diseases 4. Prevalence of tongue and lip dysfunction and distribution of tongue and lip functions in patients with lifestyle diseases

Countries

Japan

Contacts

Public ContactHiroki Takayama

Soiken, Inc. Clinical Study Support Division

takayama@soiken.com03-3295-1350

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026